Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its ...

It’s a Beast of a time in Washington. Donald Trump’s D.C. reality show is full of new characters, plot twists, and ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...

Weight loss injections can be useful aids for people who are struggling to shed unwanted pounds. GLP-1 agonist jabs, like Mounjaro and Wegovy, reduce people’s appetites. They can also slow down the ...

Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...

All three companies have had a tough time of it recently in the stock market. But in all three cases, our analysts think that ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

The Danish pharma giant's shares fell by up to 9% after Eli Lilly announced that its experimental daily pill may work just as ...

Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.

Here are three of the biggest mistakes that doctors say people make while taking Ozempic and similar medications. 🩺 SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...